Exacis Biotherapeutics Inc. logo

Exacis Biotherapeutics Inc.

mRNA-based technology to develop engineered cell therapies for solid and liquid tumors

2

Funding Rounds

$6.0m

Money raised

Overview

mRNA-based technology to develop engineered cell therapies for solid and liquid tumors